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What’s already known about this topic? 
 There is level 1 (RCT) evidence for improved neurological outcomes after open fetal 
surgery for spina bifida vs. postnatal surgery. 
 There is a lack of standardization of techniques and comparative outcome data in 
clinical trials for endoscopic fetal surgery for spina bifida.   
 
What does this study add? 
 Different techniques, their strengths, limitations and clinical implications of 
endoscopic vs. open fetal surgery for spina bifida are discussed. 
 Open fetal surgery anticipates postnatal surgery, whereas novel and less invasive 
endoscopic approaches aim to simplify the technique. 
 More data on long-term follow up of intrauterine closure of spina bifida are needed 
and open surgery is one step ahead of fetoscopic approaches.       
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INTRODUCTION (KURT HECHER) 
The fetus has become a potential patient and intrauterine surgery is a realistic option for 
fetal therapy under certain circumstances. Its aim is to prevent intrauterine fetal death or 
fetal damage owing to fetal disease for which postnatal therapy or surgery comes too late. 
Nowadays, the most frequently performed intrauterine surgery is fetoscopic laser ablation 
of placental vascular anastomoses in monochorionic twin pregnancies with severe twin-to-
twin transfusion syndrome. If left untreated, this has a mortality of 80-90% and laser 
coagulation destroys the underlying prerequisite for the syndrome by converting a 
hemodynamically monochorionic into a dichorionic placenta. This leads to a significant 
reduction in mortality and long-term morbidity of affected fetuses. Indications for fetal 
surgery are severe congenital diaphragmatic hernia (CDH) and spina bifida or 
myelomeningocele (MMC). There are three major differences between these two 
malformations. First, in severe CDH there is a high mortality owing to pulmonary hypoplasia 
and hypertension in the newborn, whereas MMC is a non-lethal malformation leading to 
lifelong neurological impairment of lower limb motor and sensory functions, incontinence 
and hindbrain herniation causing hydrocephalus, which may have to be treated postnatally 
by a ventriculo-peritoneal shunt. Second, CDH can be effectively treated by minimally 
invasive fetoscopic balloon occlusion of the trachea, which may lead to significant lung 
growth, whereas the fetoscopic approach is much more difficult in MMC, where complete 
closure of the skin defect must be achieved to avoid damage of the exposed neural tissue. 
Third, a multicenter randomized controlled trial (www.totaltrial.eu) to compare fetoscopic 
intrauterine surgery with postnatal surgery in CDH is currently in progress, whereas 
fetoscopic intrauterine surgery for MMC has been abandoned after small initial trials with 
rather sobering results.1-4 However, a RCT comparing open fetal surgery with postnatal 
neurosurgical repair, the management of myelomeningocele study [MOMS trial], reported 
improved short-term neurological outcomes in the fetal surgery group.5 Only recently a 
renaissance in fetoscopic surgery for MMC has occurred with several centers reporting new 
techniques and promising short-term results. From a maternal point of view one would 
expect fewer complications, whereas from a fetal point of view the question is whether the 
outcome is as good as for open fetal surgery. Therefore, the question for this debate was 
whether in utero therapy for spina bifida is ready for fetoscopic repair.          
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FOR (MICHAEL BELFORT) 
 
Fetoscopic surgery for the minimally invasive repair of open neural tube defects (ONTD) was 
pioneered by Bruner and Tulipan1-3 and by Farmer et al4 from San Francisco. Results were 
disappointing with a high perinatal mortality rate, and no further research into fetoscopic 
approaches occurred for almost 2 decades in the USA. Instead, an open hysterotomy 
approach was developed and studied at the 3 centers in the MOMs trial.5 Closure 
techniques at the 3 centers varied depending on the lesion size and surgeon and details 
about how the closure technique influenced the outcomes has not been reported. In 
Philadelphia,  a complex 3 layer repair technique that used extensive dissection, myofascial 
flaps, and at times patches to effect a watertight closure is recommended, however, the 
best repair has yet to be determined. In Europe however, Thomas Kohl developed a 
completely percutaneous three to five port fetoscopic technique with an extensive 
dissection and patch repair.6-8 Early outcomes were not well accepted by the fetal surgery 
community because of the high rate of preterm delivery and because long term neurological 
outcomes were not available.9,10  In Brazil, Pedreira et al.11-13 also developed a percutaneous 
fetoscopic patch repair. Results from these two groups have been progressively improving 
but detractors still point out that compared with MOMS data, fetoscopic repair is still 
associated with a higher rate of prematurity and premature rupture of the membranes 
(PPROM) at less than 37 weeks, (Pedreira et al13: 100% PPROM (10/10) at 30+/-3 weeks; 
Degenhardt et al8:  84.3% PPROM (43/51) at 30+/- 3 weeks; Adzick et al5 : 46% (36/78)), a 
higher perinatal mortality rate (Pedreira et al13: 20% - 2/10; Degenhardt et al8:  8% - 4/51; 
Adzick et al5 : 3% - 2/78) and less than equivalent neurological outcomes (need for revision 
of the repair with additional postnatal surgery ((Pedreira et al13: 29% (2/7); Degenhardt et 
al8:  not reported; Adzick et al5: 3% - 2/77).14   
Our group, in collaboration with a group in Barcelona, developed an open abdomen 
exteriorized uterus single port technique in CO2 in a sheep model using a patch and glue 
approach.15 For our human cases, however, we opted to pursue an exteriorized uterus two 
port in CO2 technique and a simplified neurosurgical repair without patches or glue.16,17 
Given that there are as many techniques being used as there are groups engaged in 
researching this type of surgery, any attempt to lump all of the results together in a meta-
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analysis comparing fetoscopy with open repair may be difficult and potentially 
misleading.18 My statements in this debate pertain to the technique developed at Texas 
Children’s Fetal Center, which differs materially from the fetosocopic techniques of others in 
its (1) exteriorized uterus approach, (2) its use of humidified and warmed CO2, (3) the 
plication of the membranes to the uterine wall, and (4) a very different neurosurgical repair. 
To attempt to lump our data with those of others would not be a fair representation of the 
field in general, especially when comparing rates of preterm premature rupture of 
membranes (PPROM), preterm delivery, perinatal mortality and neurological outcomes. 
 
There are 3 outcomes of interest that must be considered:  
(1) Maternal outcomes: We have previously shown that maternal outcomes after a 
fetoscopic repair are similar to those performed using a hysterotomy except for a 
significantly higher rate of vaginal delivery in the fetoscopy group.17 It is difficult to argue 
that open fetal surgery is safer for the mother given the obvious risks of a 7 - 10 cm 
hysterotomy. These include: bleeding at the time of surgery, uterine rupture, and need for 
cesarean section in the index and all future pregnancies, and the potential for placenta 
percreta in future pregnancies. The option of a vaginal delivery at term is also a paradigm 
shifting distinction between the two approaches and cannot be ignored. From a maternal 
aspect, we have to agree that fetoscopy is a safer and better option. 
(2) Fetal and Neonatal non-neurological outcomes: Our fetoscopic patients (Table 1) did 
comparably well with our open surgery patients with no higher rates of prematurity, 
neonatal depression, or any other non-neurological complication.17 Given that we are in the 
process of publishing all of our results I cannot be specific here, but in our latest cohort with 
a standardized technique, the mean gestational age at delivery is now well into the term 
range, with a less than 20% PPROM rate and a more than 50% rate of vaginal delivery. While 
we have to acknowledge that numbers are small and our fetoscopic group sample size is not 
equal to that of either our open group or that of the MOMS group5, and that these are 
comparisons of uncontrolled, non-randomized patients, we also have to accept that all of 
these patients were selected based on the same MOMS criteria and managed pre- and post-
operatively using the same or a similar protocol based on the published MOMS 
methodology.5 The strength of the comparison lies in the fact that we are comparing the 
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results of the fetoscopic and open approaches of a single group (Texas Children’s Fetal 
Center) with the results of the open approach from the MOMS trial.5 This removes the 
variability introduced by trying to compare the immediate neonatal results of 3 different 
fetoscopic approaches with different rates of PPROM, oligohydramnios, preterm delivery, 
gestational age at the time of delivery, and perinatal mortality from prematurity.6-8,11-
13,16,17 In my opinion this second issue is a qualified one: for our technique I am confident in 
saying that non-neurological outcome results are comparable between our fetoscopic and 
open cases and between our fetoscopic cases and those reported in the MOMS trial.5 I am 
not prepared to comment on whether the entire field, when data are aggregated, can 
demonstrate the results that we are seeing. I do believe that as we all gain experience in our 
respective techniques, and as we work together to develop a more standardized technique 
that can be rigorously tested against the open approach, we will show comparable results in 
non-neurologic outcomes.   
(3) Neurological outcome: A reasonable comparison between open and fetoscopic 
approaches is currently impossible as long as we are all performing very different repairs. 
Professor Deprest supports an extensive dissection of the defect into its separate layers 
followed by a stepwise closure utilizing multiple layers of suture material, the development 
of significant myofascial flaps, and when necessary patches to effect a watertight closure. In 
my opinion, a simple closure utilizing the available tissue with no extensive dissection 
(which limits bleeding, release of inflammatory mediators, and inevitable invasion of 
fibroblasts and scar tissue) is a more logical approach. Our technique creates a natural 
covering of the placode that we believe will heal with minimal inflammation and scarring. Of 
course at this time our data, although encouraging, are not robust enough for meaningful 
comparison with the MOMS dataset.5 We will likely need a decade to prove our point and in 
this respect my opponent has an advantage in being able to quote medium term and long 
term MOMS outcome data. Our technique (and likely those of my compatriots in the 
fetoscopic world) is still improving, and those of us performing fetoscopic open neural tube 
defect repair are just exiting our learning curves. Our team has already noted a decrease in 
leakage of CSF at birth and better reversal of hindbrain herniation rates in our latest cases 
when compared with our initial ones. We are seeing early neurological outcomes that are 
equivalent to our open cases and equivalent to the published MOMS data.5 Given that we 
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have a paper in preparation I am unable to go into specific details here. Long term outcome 
on the neurodevelopmental, behavioral, cognitive, functional motor, and bladder and sexual 
function of this cohort of people is still developing and is crucially important to collect and 
report.  
 
Thus, I hope to have convinced the audience that (1) from a maternal aspect there can be 
no question of the benefit of the fetoscopic approach, (2) the neonatal non-neurologic data 
are suggestive of equivalency for the two techniques, and (3) while it is too early to compare 
the long-term neurological outcomes, our initial data, as assessed and independently 
reviewed by our Institutional Review Board, our Data Safety and Monitoring Board, the 
Federal Drug Administration, and our Fetal Therapy Board, are promising enough to allow 
continued investigation of this methodology. I am certain that both Dr. Deprest and I can 
agree on this – that as we go forward we all need to collect the same data, using the same 
tests and criteria, in the same international registry, and then compare our outcomes with 
complete transparency to the benefit of our maternal, fetal and pediatric patients. 
 
AGAINST (JAN DEPREST) 
 
The natural history of most forms of spinal dysraphism shows progression  in utero. As a 
consequence, fetal surgery was conceived to arrest the second of two pathogenetic “hits”, 
i.e. acquired damage to the exposed cord and nerves,19-21 and cerebrospinal fluid leakage, 
acting as a suction gradient and causing a Chiari II Malformation (CM) and/or 
ventriculomegaly.20,22-25 The experimental basis for the procedure, which we currently offer 
in Leuven, essentially consists of the demonstration in animal models 
that timely and complete coverage leads to in utero reversal of the CM and rescue of 
neurologic function.21,26 Technically, one mimics what is done postnatally, i.e.  dissection of 
the placode followed by either a multi-layered repair, or in the absence of sufficient tissue, 
using graft materials. After a few initial fetoscopic attempts, the pioneers of this approach 
resorted to microneurosurgical techniques made possible thanks to broad access to the 
fetal spine.  This required hysterotomy, laparotomy and general maternal anesthesia.  
  
This article is protected by copyright. All rights reserved. 
Because surgery for this non-lethal condition also proved to incur significant maternal and 
fetal risks, our team only considered offering it after completion of the randomized 
controlled MOMS trial.5 The choice for what is called open materno-fetal surgery (OMFS) 
was not an obvious one for a team with a tradition for developing fetoscopic instruments 
and novel fetal surgical techniques or strategies.27 Furthermore, our experience to date 
demonstrates that less than half of patients we evaluate, even after they have opted to 
continue their pregnancy and traveled long distances to learn about fetal surgery, proceeds 
with the procedure.28 There is no doubt that reducing the invasiveness of the surgery would 
increase its uptake among mothers, families and physicians; yet why have we not done so?  
Today, the surgical correction of the cystic (myelomeningocele) and non-cystic variant 
(myeloschisis) of open spina bifida consists of a stepwise formal dissection of the placode at 
the zona epithelio-serosa, untethering of the ﬁlum terminale (neurulation is not consistently 
done), ideally followed by a watertight, layered coverage of the cord using the dura, 
paraspinal muscles and fascia and ﬁnally the skin (Figure 1a). There is no doubt that this is 
tremendously challenging, if not impossible with the current fetoscopic equipment and 
expertise. From a neurosurgical viewpoint, following dissection of the placode, fetoscopy 
does not even attempt primary dural closure and myelofascial coverage. Fetoscopic 
pioneers understandably resorted to alternatives either using tissue substitutes to cover the 
spinal cord at the level of the paraspinal muscles or the skin, or both combined (Figures 1b 
and 1c), or basically only closed the skin primarily. Even that is quite challenging, with 
(initial) failure rates as high as 15% or more.9,12  
The above information demonstrates that current fetoscopic operations are not 
standardized, so that it is difficult to assess the  efficacy of fetoscopic repair. Yet, we cannot 
assume  that one or more of the current fetoscopic techniques offer a neuroprotective 
effect that is equal to the open technique. As watertight closure is a conditio sine qua non 
for success, we feel that additional experimental validation of the fetoscopic approach  in 
sufficiently powered lamb studies (early induction of a sufficiently large defect, including 
myelotomy, appropriate interval till repair, comprehensive neonatal imaging, 
neurophysiologic and histological testing and assessment of adhesions to the cord) is 
required.  This is definitely not the case for the most recent technique proposed by my 
opponent. Closure of only the skin is a method which, to my knowledge, has neither 
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experimentally nor clinically been assessed before.16 Admittedly, this type of experiments 
are even relevant to OFMS, as in around 20% of open cases, graft materials are needed 
either at the level of the dura or the skin.29 Graft augmented surgery has been described in 
experimental series, yet their designs can be criticized. We are therefore currently exploring 
all of these technical aspects in our laboratory, yet we have not moved to their clinical 
implementation.  
Apart from the required animal experimental work, clinical fetoscopic programs are in 
operation, and gather very important clinical data. Their experiences should be meticulously 
documented in the same format as was and is currently being done for OMFS.30 I am sure 
that my opponent’s co-workers are doing that. However there will come a day when the 
most commonly performed fetosocpic closure technique will need to be formally compared 
to standard anatomical repair in a clinical research study.   
Fetoscopic repair is not yet standardized and all techniques require insertion of at least two 
and up to five cannulas. Furthermore, its complexity leads to at least two times longer 
operation time. Reported intra-uterine fetal death rates exceed those of open repairs. It is 
also disappointing that minimally invasive spina bifida repair does not reduce the risk for 
membrane rupture or oligohydramnios. As a consequence, the risk for preterm delivery is 
not reduced and this may eventually offset the fetal therapeutic effects.18  
In summary, fetoscopic coverage still requires general maternal anesthesia and creation of 
sufficient workspace. It remains unclear whether that space is best obtained following 
uterine exposure,16 or percutaneously.9,12,13,31 Therefore, minimally invasive spina bifida 
repair keeps on being a maternal burden. However, we are the first to acknowledge that 
avoidance of a hysterotomy, which compromises the index and future pregnancies, would 
be a tremendous step forward. Though no long-term data are available today, it is very likely 
that multiple cannulation of the pregnant uterus will have little or no effect on future 
fertility and gynecological outcome. It seems fair to extrapolate that from follow up studies 
on single cannula fetoscopic surgery for other anomalies.32 
Families, however, undertake these surgeries with the primary goal of improving outcome 
of spina bifida. Therefore, no technical modifications are justifiable that would compromise 
the fetal outcome. It is our belief today that the available peer reviewed short term data do 
not support equivalence of both approaches. Given the additional lack of properly 
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controlled mid-term outcome data, fetoscopic spina bifida repair should be considered as an 
investigational procedure and cannot surf on the findings of the MOMS trial.  
 
CONCLUSIONS (KURT HECHER) 
 
Both debaters showed clearly the advantages and limitations of the endoscopic technique 
and the open surgery by hysterotomy approach, respectively, taking into account maternal 
and fetal benefits and risks. It has to be noted, that Dr. Belfort and his group’s open 
abdomen exteriorized uterus two-port approach is different from that of other groups using 
a percutaneous fetoscopic technique. Performing a laparotomy before finally selecting the 
entry point for the fetoscope and another working port may help to gain optimal access to 
the surgical field and thereby create sufficient working space. Furthermore, the fetoscopic 
and the open approaches are different regarding the closure techniques. The endoscopic 
closure is performed with a unified layer of undissected dura, in contrast to many other 
endoscopic techniques without the application of patches or glues. The open closure 
technique consists of a multilayered repair that includes the dura, musculofascial structures 
and the skin after dissection of the placode and untethering of the filum terminale, thereby 
imitating and anticipating the postnatal technique. Dr. Belfort argues that his approach is 
simpler and less traumatic and may, therefore, cause less inflammation and scarring. Both 
debaters agree that a watertight closure is the primary aim of intrauterine surgery, 
otherwise the protective effect against damage of the exposed spinal cord cannot be 
expected. Whether this can be achieved equally effective by both approaches still remains 
to be shown by comparative studies.            
Dr. Belfort focuses on maternal, fetal and neonatal non-neurological and early neurological 
outcomes. For the mother, open fetal surgery has clearly higher risks owing to hysterotomy, 
which affects the index and all future pregnancies with the need for cesarean section, while 
the endoscopic approach allows vaginal delivery. Furthermore, bleeding, uterine rupture 
and morbidly adherent placenta are typical risks after hysterotomy. Dr. Deprest agrees that 
avoidance of hysterotomy would be a tremendous step forward, if the endoscopic surgery 
can be done as effectively as the open one. He rightly points out that woman agree to and 
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bear the burden of this surgery under the condition that the primary aim of it, namely an 
improvement of long term morbidity of their child, is achieved, as this is not a lethal 
malformation, for which a live saving intervention would be indicated. Dr. Belfort confirms 
that fetoscopic surgeons are just exiting the steeper slopes of growing experience of their 
learning curves and early neurological outcomes seem to be equivalent to the published 
MOMS trial data. However, sufficient long-term outcome data are not yet available. 
In contrast to endoscopic surgery, long term outcome data are available for open surgery. A 
recent study reported long term data on neurofunctional outcome from a pre MOMS 
population with open repair.33 At a median age of ten years, 79% were community 
ambulators and only 14% were wheelchair dependent. More than expected were continent, 
but bowel and bladder control were still ongoing challenges. Abnormalities of behavioral 
adaptive skills were more common than impairments in executive functioning, and they 
were associated with the need for shunting.     
Taking into account the variety of fetoscopic techniques with insertion of two up to five 
cannulas and the potential technical difficulties leading to a considerably longer time of 
surgery needed for endoscopic repair, Dr. Deprest calls for more experimental trials and 
standardization of the techniques. After this has been achieved, there will be an urgent 
need for a randomized controlled trial to compare neurological outcomes with those after 
open fetal surgery, with surgery being performed in centers of excellence for each 
respective technique. In the meantime, proof of concept innovative surgery in animal 
models followed by  human cases may lead to novel methods of patch repair for the open as 
well as the fetoscopic approach in cases with large defects in which primary closure is 
difficult.34 
Iatrogenic prematurity is still a major complication of all techniques of intrauterine surgery 
for spina bifida, regardless whether it is done by fetoscopy or hysterotomy. In all major 
studies, the mean gestational age at delivery is consistently around 34 weeks. One may 
wonder, whether on its own this may be a major factor leading to improved outcomes, 
owing to an average reduction of six weeks of exposure to the toxic amniotic fluid. To test 
this hypothesis, I would propose a randomized controlled trial comparing the most 
standardized surgical technique, which at the moment is certainly the open approach of the 
MOMS trial, with conservative management followed by elective cesarean section at 34 
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weeks of gestation. A multidisciplinary working group would be needed to investigate 
whether this would be justified, feasible and ethically approvable.                    
In conclusion, there is agreement that the strengths of open fetal surgery for spina bifida 
repair are the standardization of the technique and that it is the only one for which evidence 
based neurological outcome data in comparison to postnatal surgery are available. 
However, the search for an endoscopic technique, which is less invasive for the mother and 
equally beneficial for the fetus must be pursued and, once standardization has been 
achieved, rigorously tested in clinical trials. In selected centers, and within the framework of 
research protocols, in utero therapy for spina bifida is ready for endoscopic repair.  
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Table 1: Maternal and fetal outcome data comparing endoscopic (ENDO) and open (OPEN) fetal 
repair. 
  
Data: mean +/- standard deviation or n(%) 
ENDO 
(n = 10) 
OPEN 
(n=20) 
P 
value 
Fetal bradycardia intraoperative 0/10 (0%) 2/20 (10%) 0.8 
Chorion-amnion separation 2/9 (22%) 2/20 (10%) 0.38 
Postoperative oligohydramnios 3/10 (30%) 4/20 (20%) 0.54 
Gestational Age (GA) at delivery (weeks) 36.3 +/- 2.9 33.8 +/- 3.7 0.12 
Preterm Premature Rupture of Membranes 
(PPROM) 
2/9 (22%) 7/20 (35%) 0.49 
Interval: Fetal surgery to delivery (weeks) 11.5 +/- 2.8 9.4 +/- 4.2 0.24 
Upper Segment Hysterotomy 0/10 (0%) 
20/20 
(100%) 
0.00 
Vaginal Delivery 
3/7 (43%) *3 cases undelivered as of 
8/8/2015 
0/20 (0%) 0.002 
Birth Weight (g) 2562 +/- 657 
2344 +/- 
640 
0.51 
Maternal Length of Stay after fetal surgery 
(LOS) 
5 +/- 1 7 +/- 3 0.19 
Neonatal LOS after delivery: median [range] 6 [2 - 31] 7 [2 - 51] 0.9 
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Figure 1: Schematic drawing of neurosurgical closure following dissection and untethering, either (a) through multilayered repair involving the dura, 
musculofascial structures and skin; or using (b) a dural or (c) skin substitute. In some reports two grafts are used to assist myofascial and skin closure (12). 
Reproduced, with permission from the University Hospitals Leuven and Myrthe Boymans, artist.  
 
  
 
 
  
a. Anatomical multilayered repair.  b. dural substitute as described in (11, 12) 
consisting of a biocellulose patch.  
c. substitution of skin closure as described in 
(31) 
 
 
